Skip to main content

Advertisement

SpringerLink
Log in

Modulation of Anticonvulsant Effects of Cannabinoid Compounds by GABA-A Receptor Agonist in Acute Pentylenetetrazole Model of Seizure in Rat

  • Original Paper
  • Published:
Neurochemical Research Aims and scope Submit manuscript

Abstract

Cannabinoid system plays an important role in controlling neuronal excitability and brain function. On the other hand, modulation of gamma-aminobutyric acid (GABA) transmission is one of the initial strategies for the treatment of seizure. The aim of the present study was to evaluate possible interaction between cannabinoidergic and GABAergic systems in pentylenetetrazole (PTZ)-induced acute seizure in rat. Drugs were administered by intracerebroventricular (i.c.v.) administration 20 min before a single intraperitoneal (i.p.) injection of PTZ and the latency to the first generalized tonic-clonic seizure was measured. Both the cannabinoid receptor agonist WIN55212-2 (10, 30, 50 and 100 μg/rat) and the GABA-A receptor agonist isoguvacine (IGN; 10, 30 and 50 μg/rat) significantly increased the latency of seizure occurrence. Moreover, the fatty acid amide hydrolase inhibitor URB597 showed no anticonvulsive effect while the monoacyl glycerol lipase (MAGL) inhibitor URB602 (10, 50 and 100 μg/rat) protected rats against PTZ-induced seizure. Moreover, co-administration of IGN and cannabinoid compounds attenuated the anticonvulsant action of both WIN55212-2 and IGN in this model of seizure. Our data suggests that exogenous cannabinoid WIN55212-2 and MAGL inhibitor URB602 imply their antiseizure action in part through common brain receptorial system. Moreover, the antagonistic interaction of cannabinoids and IGN in protection against PTZ-induced seizure could suggest the involvement of GABAergic system in their anticonvulsant action.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Fisher RS, van Emde Boas W, Blume W et al (2005) Epileptic seizures and epilepsy: definitions proposed by the international league against epilepsy (ILAE) and the international bureau for epilepsy (IBE). Epilepsia 46:470–472

    Article  PubMed  Google Scholar 

  2. Blair RE, Deshpande LS, Sombati S et al (2006) Activation of the cannabinoid type-1 receptor mediates the anticonvulsant properties of cannabinoids in the hippocampal neuronal culture models of acquired epilepsy and status epilepticus. J Pharmacol Exp Ther 317:1072–1078

    Article  PubMed  CAS  Google Scholar 

  3. Falenski KW, Blair RE, Sim-Selley LJ et al (2007) Status epilepticus causes a long-lasting redistribution of hippocampal cannabinoid type 1 receptor expression and function in the rat pilocarpine model of acquired epilepsy. Neuroscience 146:1232–1244

    Article  PubMed  CAS  Google Scholar 

  4. Lutz B, Monory K (2008) Soothing the seizures of children. Nat Med 14:721–722

    Article  PubMed  CAS  Google Scholar 

  5. Salzet M (2000) Invertebrate molecular neuroimmune processes. Brain Res Brain Res Rev 34:69–79

    Article  PubMed  CAS  Google Scholar 

  6. Ludanyi A, Eross L, Czirjak S et al (2008) Downregulation of the CB1 cannabinoid receptor and related molecular elements of the endocannabinoid system in epileptic human hippocampus. J Neurosci 28:2976–2990

    Article  PubMed  CAS  Google Scholar 

  7. Rogawski MA (1998) Mechanism-specific pathways for new antiepileptic drug discovery. Adv Neurol 76:11–27

    PubMed  CAS  Google Scholar 

  8. Isaev D, Isaeva E, Khazipov R et al (2005) Anticonvulsant action of GABA in the high potassium-low magnesium model of ictogenesis in the neonatal rat hippocampus in vivo and in vitro. J Neurophysiol 94:2987–2992

    Article  PubMed  CAS  Google Scholar 

  9. Takeda A, Itoh H, Hirate M et al (2006) Region-specific loss of zinc in the brain in pentylentetrazole-induced seizures and seizure susceptibility in zinc deficiency. Epilepsy Res 70:41–48

    Article  PubMed  CAS  Google Scholar 

  10. Macdonald RL, Kelly KM (1995) Antiepileptic drug mechanisms of action. Epilepsia 36(Suppl 2):S2–S12

    Google Scholar 

  11. Lemos JI, Takahashi RN, Morato GS (2007) Effects of SR141716 and WIN 55, 212–2 on tolerance to ethanol in rats using the acute and rapid procedures. Psychopharmacology (Berl) 194:139–149

    Article  CAS  Google Scholar 

  12. Murillo-Rodriguez E, Vazquez E, Millan-Aldaco D et al (2007) Effects of the fatty acid amide hydrolase inhibitor URB597 on the sleep-wake cycle, c-Fos expression and dopamine levels of the rat. Eur J Pharmacol 562:82–91

    Article  PubMed  CAS  Google Scholar 

  13. Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates. Elsevier Academic Press, San Diego

  14. Oommen J, Kraus AC, Fisher RS (2007) Intraventricular administration of gabapentin in the rat increases flurothyl seizure threshold. Neurosci Lett 417:308–311

    Article  PubMed  CAS  Google Scholar 

  15. Szot P, Weinshenker D, White SS et al (1999) Norepinephrine-deficient mice have increased susceptibility to seizure-inducing stimuli. J Neurosci 19:10985–10992

    PubMed  CAS  Google Scholar 

  16. Litchfield JT Jr, Wilcoxon F (1949) A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther 96:99–113

    PubMed  CAS  Google Scholar 

  17. Wallace MJ, Wiley JL, Martin BR et al (2001) Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects. Eur J Pharmacol 428:51–57

    Article  PubMed  CAS  Google Scholar 

  18. Naderi N, Aziz Ahari F, Shafaghi B et al (2008) Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice. J Neural Transm 115:1501–1511

    Article  PubMed  CAS  Google Scholar 

  19. Shen M, Piser TM, Seybold VS et al (1996) Cannabinoid receptor agonists inhibit glutamatergic synaptic transmission in rat hippocampal cultures. J Neurosci 16:4322–4334

    PubMed  CAS  Google Scholar 

  20. Leach MJ, Marden CM, Miller AA (1986) Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia 27:490–497

    Article  PubMed  CAS  Google Scholar 

  21. Meldrum BS (1994) The role of glutamate in epilepsy and other CNS disorders. Neurology 44:S14–S23

    PubMed  CAS  Google Scholar 

  22. Freund TF, Katona I, Piomelli D (2003) Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83:1017–1066

    PubMed  CAS  Google Scholar 

  23. White WF, Snodgrass SR (1983) Isoguvacine binding, uptake, and release: relation to the GABA system. J Neurochem 40:1701–1708

    Article  PubMed  CAS  Google Scholar 

  24. Misgeld U, Frotscher M (1986) Postsynaptic-GABAergic inhibition of non-pyramidal neurons in the guinea-pig hippocampus. Neuroscience 19:193–206

    Article  PubMed  CAS  Google Scholar 

  25. Kandel ER, Schwartz JH, Jessell TM (2000) Seizures and epilepsy. In: Principles of neural sciences. Mc Graw-Hill, New York, pp 910–935

    Google Scholar 

  26. Marinelli S, Pacioni S, Cannich A et al (2009) Self-modulation of neocortical pyramidal neurons by endocannabinoids. Nat Neurosci 12:1488–1491

    Article  PubMed  CAS  Google Scholar 

  27. Marinelli S, Pacioni S, Bisogno T et al (2008) The endocannabinoid 2-arachidonoylglycerol is responsible for the slow self-inhibition in neocortical interneurons. J Neurosci 28:13532–13541

    Article  PubMed  CAS  Google Scholar 

  28. Di Marzo V, Bifulco M, De Petrocellis L (2004) The endocannabinoid system and its therapeutic exploitation. Nat Rev Drug Discov 3:771–784

    Article  PubMed  CAS  Google Scholar 

  29. Dinh TP, Carpenter D, Leslie FM et al (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci USA 99:10819–10824

    Article  PubMed  CAS  Google Scholar 

  30. Chevaleyre V, Castillo PE (2003) Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron 38:461–472

    Article  PubMed  CAS  Google Scholar 

  31. Egertova M, Cravatt BF, Elphick MR (2003) Comparative analysis of fatty acid amide hydrolase and cb(1) cannabinoid receptor expression in the mouse brain: evidence of a widespread role for fatty acid amide hydrolase in regulation of endocannabinoid signaling. Neuroscience 119:481–496

    Article  PubMed  CAS  Google Scholar 

  32. Ameri A, Wilhelm A, Simmet T (1999) Effects of the endogeneous cannabinoid, anandamide, on neuronal activity in rat hippocampal slices. Br J Pharmacol 126:1831–1839

    Article  PubMed  CAS  Google Scholar 

  33. Maccarrone M, Rossi S, Bari M et al (2008) Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum. Nat Neurosci 11:152–159

    Article  PubMed  CAS  Google Scholar 

  34. Marsicano G, Goodenough S, Monory K et al (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302:84–88

    Article  PubMed  CAS  Google Scholar 

  35. Wallace MJ, Blair RE, Falenski KW et al (2003) The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J Pharmacol Exp Ther 307:129–137

    Article  PubMed  CAS  Google Scholar 

  36. Sugiura T, Yoshinaga N, Kondo S et al (2000) Generation of 2-arachidonoylglycerol, an endogenous cannabinoid receptor ligand, in picrotoxinin-administered rat brain. Biochem Biophys Res Commun 271:654–658

    Article  PubMed  CAS  Google Scholar 

  37. Solbrig MV, Adrian R, Baratta J et al (2005) A role for endocannabinoids in viral-induced dyskinetic and convulsive phenomena. Exp Neurol 194:355–362

    Article  PubMed  CAS  Google Scholar 

  38. Moesgaard B, Hansen HH, Hansen SL et al (2003) Brain levels of N-acylethanolamine phospholipids in mice during pentylenetetrazol-induced seizure. Lipids 38:387–390

    Article  PubMed  CAS  Google Scholar 

  39. Kim J, Alger BE (2010) Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. Nat Neurosci 13:592–600

    Article  PubMed  CAS  Google Scholar 

  40. Urbanski MJ, Kovacs FE, Szabo B (2009) Depolarizing GABAergic synaptic input triggers endocannabinoid-mediated retrograde synaptic signaling. Synapse 63:643–652

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by a grant (No. 1138) from Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Author information

Authors and Affiliations

  1. Neuroscience Research Center, Shahid Beheshti University of Medical Sciences, P.O. Box 19615-1178, Tehran, Iran

    Nima Naderi, Leila Ahmad-Molaei, Farzad Aziz Ahari & Fereshteh Motamedi

Authors
  1. Nima Naderi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Leila Ahmad-Molaei
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Farzad Aziz Ahari
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fereshteh Motamedi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nima Naderi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Naderi, N., Ahmad-Molaei, L., Aziz Ahari, F. et al. Modulation of Anticonvulsant Effects of Cannabinoid Compounds by GABA-A Receptor Agonist in Acute Pentylenetetrazole Model of Seizure in Rat. Neurochem Res 36, 1520–1525 (2011). https://doi.org/10.1007/s11064-011-0479-1

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11064-011-0479-1

Keywords

Search

Navigation